Biomedical Engineering Reference
In-Depth Information
207. Illum, L.; Farraj, N. F.; Davis, S. S. Chitosan as a Novel Nasal Delivery System for Peptide
Drugs.
Pharm. Res.
1994,
11,
1186-1189.
208. Aspden, T. J.; Mason, J. D.; Jones, N. S. Chitosan as a Nasal Delivery System: The Effect of
Chitosan Solutions on in Vitro and in Vivo Mucociliary Transport Rates in Human Turbinates
and volunteers.
J. Pharm. Sci.
1997,
86,
509-513.
209. Erbacher, P.; Zou, S.; Bettinger, T.; Steffan, A. M.; Remy, J. S. Chitosan-Based Vector/DNA
Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability.
Pharm.
Res.
1998,
15,
1332-1339.
210. Pille, J. Y.; Li, H.; Blot, E.; Bertrand, J. R.; Pritchard, L. L.; Opolon, P., et al. Intravenous Deliv-
ery of Anti-RhoA Small Interfering NA Loaded in Nanoparticles of Chitosan in Mice: Safety
and Efficacy in Xenografted Aggressive Breast Cancer.
Hum. Gene. Ther.
2006,
17,
1019-1026.
211. Govender, T.; Stolnik, S.; Garnett, M. C.; Illum, L.; Davis, S. S. PLGA Nanoparticles Prepared
by Nanoprecipitation: Drug Loading and Release Studies of a Water Soluble Drug.
J. Con-
trolled. Release.
1999,
57,
171-185.
212. Panyam, J.; Sahoo, S. K.; Prabha, S.; Bargar, T.; Labhasetwar, V. Fluorescence and Elec-
tron Microscopy Probes for Cellular and Tissue Uptake of polyD L -lactide-
co
-glycolide)
Nanoparticles.
Int. J. Pharm.
2003,
262,
1-11.
213. Panyam, J.; Williams, D.; Dash, A.; Leslie-Pelecky, D.; Labhasetwar, V. Solid-State Solubility
Influences Encapsulation and Release of Hydrophobic Drugs from PLGA/PLA Nanoparticles.
J. Pharm. Sci.
2004,
93,
1804-1814.
214. Wang, Y. -C.; Wu, Y. -T.; Huang, H. -Y.; Lin, H. -I.; Lo, L. -W.; Tzeng, S. -F., et al. Sustained
Intraspinal Delivery of Neurotrophic Factor Encapsulated in Biodegradable Nanoparticles fol-
lowing Contusive Spinal Cord Injury.
Biomaterials
2008,
29,
4546-4553.
215. Tran, P. A.; Zhang, L.; Webster, T. J. Carbon Nanofibers and Carbon Nanotubes in Regenera-
tive Medicine.
Adv. Drug. Deliv. Rev.
2009,
61,
1097-1114.
216. Bakry, R.; Vallant, R. M.; Najam-ul-hag, M.; Rainer, M.; Szabo, Z.; Huck, C. W., et al. Medic-
inal Applications of Fullerenes.
Int. J. Nanomed.
2007,
2,
639-649.
217. Wang, J.; Musameh, M.; Lin, Y. Solubilization of Carbon Nanotubes by Nafion Toward the
Preparation of Amperometric Biosensors.
J. Am. Chem. Soc.
2003,
125,
2408-2409.
218. Dang, J. M.; Leong, K. W. Natural Polymers for Gene Delivery and Tissue Engineering.
Adv.
Drug. Deliv. Rev.
2006,
58,
487-499.
219. Ge, H.; Hu, Y.; Jiang, X.; Cheng, D.; Yuan, Y.; Bi, H., et al. Preparation, Characterization,
and Drug Release Behaviors of Drug Nimodipine-Loaded Poly(Epsilon-Caprolactone)-
Poly(Ethylene Oxide)-Poly(Epsilon-Caprolactone) Amphiphilic Triblock Copolymer
Micelles.
J. Pharm. Sci.
2002,
91,
1463-1473.
220. Gelperina, S. E.; Khalansky, A. S.; Skidan, I. N.; Smirnova, Z. S.; Bobruskin, A. I.; Severin,
S. E., et al. Toxicological Studies of Doxorubicin Bound to Polysorbate 80-Coated Poly(Butyl
Cyanoacrylate) Nanoparticles in Healthy Rats and Rats with Intracranial Glioblastoma.
Toxi-
col. Lett.
2002,
126,
131-141.
221. Linhardt, R. J. In
Controlled Release of Drugs
; Rosoff, M., Ed.; VCH Publishers: New York,
NY, 1989; pp 53-95.
222. Kreuter, J.
Nanoparticles
; M. Dekker: New York, NY, 1994.
223. Armentano, I.; Dottori, M.; Fortunati, E.; Mattioli, S.; Kenny, J. M. Biodegradable Polymer
Matrix Nanocomposites for Tissue Engineering: A Review.
Polym. Degrad. Stab.
2010,
95,
2126-2146.
224. Koegler, W. S.; Griffith, L. G. Osteoblast Response to PLGA Tissue Engineering Scaffolds
with PEO Modified Surface Chemistries and Demonstration of Patterned Cell Response.
Biomaterials
2004,
25,
2819-2830.
